These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14668706)

  • 21. MR contrast agents: physical and pharmacologic basics.
    Lin SP; Brown JJ
    J Magn Reson Imaging; 2007 May; 25(5):884-99. PubMed ID: 17457803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update to pulse sequences for interventional MR imaging.
    Derakhshan JJ; Duerk JL
    Magn Reson Imaging Clin N Am; 2005 Aug; 13(3):415-29. PubMed ID: 16084410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracranial carotid MR imaging at 3T.
    DeMarco JK; Huston J; Nash AK
    Magn Reson Imaging Clin N Am; 2006 Feb; 14(1):109-21. PubMed ID: 16530639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaesthesia problems in angiography with special reference to modern contrast media.
    Wenz W; Wiemers K; Schlürmann D; Reinbold WD; Anger P
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():92-101. PubMed ID: 6139086
    [No Abstract]   [Full Text] [Related]  

  • 26. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
    J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral MR angiography.
    Kramer H; Nikolaou K; Sommer W; Reiser MF; Herrmann KA
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):91-100. PubMed ID: 19364602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance angiography (MRA) in renally impaired patients: when and how.
    Bongartz G; Mayr M; Bilecen D
    Eur J Radiol; 2008 May; 66(2):213-9. PubMed ID: 18329834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in contrast agents.
    Bettmann MA; Morris TW
    Radiol Clin North Am; 1986 Sep; 24(3):347-57. PubMed ID: 3529226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transient cortical blindness following the administration of angiographic contrasts].
    Marín-Herrero M; Fernández-Bolaños Porras R; Galán-Barranco JM; del Río-Oliva C; Gutiérrez-Del Manzano JA
    Rev Neurol; 2007 May 1-15; 44(9):562-3. PubMed ID: 17492616
    [No Abstract]   [Full Text] [Related]  

  • 33. Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans.
    Vancraeynest D; Kefer J; Hanet C; Fillee C; Beauloye C; Pasquet A; Gerber BL; Philippe M; Vanoverschelde JL
    Eur Heart J; 2007 May; 28(10):1236-41. PubMed ID: 17409107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thorotrast. How an immediate success can become a failure in the long run].
    Andersson M
    Ugeskr Laeger; 2000 Jan; 162(1):50-1. PubMed ID: 10658497
    [No Abstract]   [Full Text] [Related]  

  • 35. [Round-table discussion of the complications of cardiovascular radiography with contrast media. Introduction].
    Pistolesi GF
    Radiol Med; 1978 Apr; 64(4):455-7. PubMed ID: 704971
    [No Abstract]   [Full Text] [Related]  

  • 36. [Historical outline of contrast studies of the cardiovascular system].
    Szczepański J
    Wiad Lek; 1968 Jun; 21(12):1085-7. PubMed ID: 4875372
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticoagulant activity of angiographic contrast media.
    Bernstein EF; Gans H
    Invest Radiol; 1966; 1(2):162-8. PubMed ID: 5929960
    [No Abstract]   [Full Text] [Related]  

  • 38. Nonionic contrast media in radiology. Procedural considerations.
    Robertson HJ
    Invest Radiol; 1988 Nov; 23 Suppl 2():S374-7. PubMed ID: 3058642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the effect of angiographic contrast media on the cardiovascular and respiratory system].
    Zsebök ZB; Szlávy L
    Fortschr Geb Rontgenstr Nuklearmed; 1966 Sep; 105(3):406-15. PubMed ID: 6011682
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental therapy and prophylaxis of thrombosis in x-ray contrast examination of vessels].
    Sergeev PV; Lakin KM
    Patol Fiziol Eksp Ter; 1966; 10(3):20-2. PubMed ID: 5239867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.